These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23861802)

  • 21. Superoxide dismutases, lung function and bronchial responsiveness in a general population.
    Siedlinski M; van Diemen CC; Postma DS; Vonk JM; Boezen HM
    Eur Respir J; 2009 May; 33(5):986-92. PubMed ID: 19213780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signatures for chronic obstructive pulmonary disease (COPD) and asthma: a comparative genetic analysis.
    Sahu A; Swaroop S; Kant S; Banerjee M
    Br J Biomed Sci; 2021 Oct; 78(4):177-183. PubMed ID: 33740392
    [No Abstract]   [Full Text] [Related]  

  • 23. Association of a disintegrin and metalloproteinase 33 (ADAM33) gene polymorphisms with chronic obstructive pulmonary disease in the Chinese population: a meta-analysis.
    Li DD; Guo SJ; Jia LQ; Wen FQ
    Genet Mol Res; 2014 Aug; 13(3):6391-7. PubMed ID: 25158257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haplotype analysis of
    Vishweswaraiah S; Ramachandra NB; Jayaraj BS; Holla AD; Chakraborty S; Agrawal A; Mahesh PA
    Indian J Med Res; 2019 Sep; 150(3):272-281. PubMed ID: 31719298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers.
    Kupiainen H; Kuokkanen M; Kontto J; Virtamo J; Salomaa V; Lindqvist A; Kilpeläinen M; Laitinen T
    COPD; 2016 Aug; 13(4):464-70. PubMed ID: 26751916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mendelian randomization study of interleukin-6 in chronic obstructive pulmonary disease.
    van Durme YM; Lahousse L; Verhamme KM; Stolk L; Eijgelsheim M; Loth DW; Uitterlinden AG; Breteler MM; Joos GF; Hofman A; Stricker BH; Brusselle GG
    Respiration; 2011; 82(6):530-8. PubMed ID: 21997388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of gene environment interactions on lung function and cardiovascular disease in COPD.
    Hackett TL; Stefanowicz D; Aminuddin F; Sin DD; Connett JE; Anthonisen NR; Paré PD; Sandford AJ
    Int J Chron Obstruct Pulmon Dis; 2011; 6():277-87. PubMed ID: 21814463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Airflow limitation classified with the fixed ratio or the lower limit of normal and cause-specific mortality - A prospective study.
    Torén K; Andersson M; Olin AC; Blanc PD; Järvholm B
    Respir Med; 2018 Nov; 144():36-41. PubMed ID: 30366582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABCC1 polymorphisms contribute to level and decline of lung function in two population-based cohorts.
    Siedlinski M; Boezen HM; Boer JM; Smit HA; Postma DS
    Pharmacogenet Genomics; 2009 Sep; 19(9):675-84. PubMed ID: 19687781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smoking and obesity associated BDNF gene variance predicts total and cardiovascular mortality in smokers.
    Halldén S; Sjögren M; Hedblad B; Engström G; Narkiewicz K; Hoffmann M; Wahlstrand B; Hedner T; Melander O
    Heart; 2013 Jul; 99(13):949-53. PubMed ID: 23624487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variants of ADAM33 are associated with asthma susceptibility in the Punjabi population of Pakistan.
    Sabar MF; Ghani MU; Shahid M; Sumrin A; Ali A; Akram M; Tariq MA; Bano I
    J Asthma; 2016; 53(4):341-8. PubMed ID: 26666372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD.
    Fawzy A; Anderson JA; Cowans NJ; Crim C; Wise R; Yates JC; Hansel NN
    Respir Res; 2019 May; 20(1):86. PubMed ID: 31068182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic Variants in IL6R and ADAM19 are Associated with COPD Severity in a Mexican Mestizo Population.
    Pérez-Rubio G; Silva-Zolezzi I; Fernández-López JC; Camarena Á; Velázquez-Uncal M; Morales-Mandujano F; Hernández-Zenteno Rde J; Flores-Trujillo F; Sánchez-Romero C; Velázquez-Montero A; Espinosa de Los Monteros C; Sansores RH; Ramírez-Venegas A; Falfán-Valencia R
    COPD; 2016 Oct; 13(5):610-5. PubMed ID: 27078193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease.
    van Durme YM; Verhamme KM; Aarnoudse AJ; Van Pottelberge GR; Hofman A; Witteman JC; Joos GF; Brusselle GG; Stricker BH
    Am J Respir Crit Care Med; 2009 Mar; 179(5):375-82. PubMed ID: 19096002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular Outcomes and All-Cause Mortality in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (Overlap Syndrome).
    Kendzerska T; Leung RS; Aaron SD; Ayas N; Sandoz JS; Gershon AS
    Ann Am Thorac Soc; 2019 Jan; 16(1):71-81. PubMed ID: 30372124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex-Based Genetic Association Study Identifies CELSR1 as a Possible Chronic Obstructive Pulmonary Disease Risk Locus among Women.
    Hardin M; Cho MH; Sharma S; Glass K; Castaldi PJ; McDonald ML; Aschard H; Senter-Sylvia J; Tantisira K; Weiss ST; Hersh CP; Morrow JD; Lomas D; Agusti A; Bakke P; Gulsvik A; O'Connor GT; Dupuis J; Hokanson J; Crapo JD; Beaty TH; Laird N; Silverman EK; DeMeo DL;
    Am J Respir Cell Mol Biol; 2017 Mar; 56(3):332-341. PubMed ID: 27854507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of Superoxide Dismutase-1 Genetic Variation on Cardiovascular and All-Cause Mortality in a Prospective Cohort Study: The Yamagata (Takahata) Study.
    Otaki Y; Watanabe T; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Konta T; Shibata Y; Sato H; Kawasaki R; Daimon M; Ueno Y; Kato T; Kayama T; Kubota I
    PLoS One; 2016; 11(10):e0164732. PubMed ID: 27755600
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Reséndiz-Hernández JM; Ambrocio-Ortiz E; Pérez-Rubio G; López-Flores LA; Abarca-Rojano E; Pavón-Romero GF; Flores-Trujillo F; de Jesús Hernández-Zenteno R; Camarena Á; Pérez-Rodríguez M; Salazar AM; Ramírez-Venegas A; Falfán-Valencia R
    Int J Chron Obstruct Pulmon Dis; 2018; 13():627-637. PubMed ID: 29497291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of tumor necrosis factor-alpha-863C/A gene polymorphism with chronic obstructive pulmonary disease.
    Chen YC; Liu SF; Chin CH; Wu CC; Chen CJ; Chang HW; Wang YH; Chung YH; Chao TY; Lin MC
    Lung; 2010 Aug; 188(4):339-47. PubMed ID: 20352242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide association study on the FEV
    van der Plaat DA; de Jong K; Lahousse L; Faiz A; Vonk JM; van Diemen CC; Nedeljkovic I; Amin N; Brusselle GG; Hofman A; Brandsma CA; Bossé Y; Sin DD; Nickle DC; van Duijn CM; Postma DS; Boezen HM
    J Allergy Clin Immunol; 2017 Feb; 139(2):533-540. PubMed ID: 27612410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.